These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 31805015)

  • 1. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
    Smith GI; Shankaran M; Yoshino M; Schweitzer GG; Chondronikola M; Beals JW; Okunade AL; Patterson BW; Nyangau E; Field T; Sirlin CB; Talukdar S; Hellerstein MK; Klein S
    J Clin Invest; 2020 Mar; 130(3):1453-1460. PubMed ID: 31805015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics.
    Smith GI; Polidori DC; Yoshino M; Kearney ML; Patterson BW; Mittendorfer B; Klein S
    J Clin Invest; 2020 Jun; 130(6):3305-3314. PubMed ID: 32191646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease.
    Fuchs A; Samovski D; Smith GI; Cifarelli V; Farabi SS; Yoshino J; Pietka T; Chang SW; Ghosh S; Myckatyn TM; Klein S
    Gastroenterology; 2021 Sep; 161(3):968-981.e12. PubMed ID: 34004161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary sugar restriction reduces hepatic de novo lipogenesis in adolescent boys with fatty liver disease.
    Cohen CC; Li KW; Alazraki AL; Beysen C; Carrier CA; Cleeton RL; Dandan M; Figueroa J; Knight-Scott J; Knott CJ; Newton KP; Nyangau EM; Sirlin CB; Ugalde-Nicalo PA; Welsh JA; Hellerstein MK; Schwimmer JB; Vos MB
    J Clin Invest; 2021 Dec; 131(24):. PubMed ID: 34907907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
    Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
    Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis.
    Green CJ; Marjot T; Walsby-Tickle J; Charlton C; Cornfield T; Westcott F; Pinnick KE; Moolla A; Hazlehurst JM; McCullagh J; Tomlinson JW; Hodson L
    Eur J Endocrinol; 2022 Feb; 186(3):367-377. PubMed ID: 35038311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
    Baykal AP; Parks EJ; Shamburek R; Syed-Abdul MM; Chacko S; Cochran E; Startzell M; Gharib AM; Ouwerkerk R; Abd-Elmoniem KZ; Walter PJ; Walter M; Muniyappa R; Chung ST; Brown RJ
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content.
    Fabbrini E; deHaseth D; Deivanayagam S; Mohammed BS; Vitola BE; Klein S
    Obesity (Silver Spring); 2009 Jan; 17(1):25-9. PubMed ID: 18948971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Adipose Tissue Fibrogenesis, Not Impaired Expandability, Is Associated With Nonalcoholic Fatty Liver Disease.
    Beals JW; Smith GI; Shankaran M; Fuchs A; Schweitzer GG; Yoshino J; Field T; Matthews M; Nyangau E; Morozov D; Mittendorfer B; Hellerstein MK; Klein S
    Hepatology; 2021 Sep; 74(3):1287-1299. PubMed ID: 33743554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents.
    Deivanayagam S; Mohammed BS; Vitola BE; Naguib GH; Keshen TH; Kirk EP; Klein S
    Am J Clin Nutr; 2008 Aug; 88(2):257-62. PubMed ID: 18689359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
    Softic S; Cohen DE; Kahn CR
    Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease.
    Ter Horst KW; Vatner DF; Zhang D; Cline GW; Ackermans MT; Nederveen AJ; Verheij J; Demirkiran A; van Wagensveld BA; Dallinga-Thie GM; Nieuwdorp M; Romijn JA; Shulman GI; Serlie MJ
    Diabetes Care; 2021 Feb; 44(2):489-498. PubMed ID: 33293347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
    Amaro A; Fabbrini E; Kars M; Yue P; Schechtman K; Schonfeld G; Klein S
    Gastroenterology; 2010 Jul; 139(1):149-53. PubMed ID: 20303351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars.
    Luukkonen PK; Sädevirta S; Zhou Y; Kayser B; Ali A; Ahonen L; Lallukka S; Pelloux V; Gaggini M; Jian C; Hakkarainen A; Lundbom N; Gylling H; Salonen A; Orešič M; Hyötyläinen T; Orho-Melander M; Rissanen A; Gastaldelli A; Clément K; Hodson L; Yki-Järvinen H
    Diabetes Care; 2018 Aug; 41(8):1732-1739. PubMed ID: 29844096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fructose as a key player in the development of fatty liver disease.
    Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
    World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects.
    Korenblat KM; Fabbrini E; Mohammed BS; Klein S
    Gastroenterology; 2008 May; 134(5):1369-75. PubMed ID: 18355813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease.
    Bril F; Barb D; Portillo-Sanchez P; Biernacki D; Lomonaco R; Suman A; Weber MH; Budd JT; Lupi ME; Cusi K
    Hepatology; 2017 Apr; 65(4):1132-1144. PubMed ID: 27981615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver.
    Fu X; Fletcher JA; Deja S; Inigo-Vollmer M; Burgess SC; Browning JD
    J Clin Invest; 2023 May; 133(9):. PubMed ID: 36928190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
    Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
    J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLX plays a key role in lipid and glucose metabolism in humans: Evidence from in vitro and in vivo studies.
    Nagarajan SR; Livingstone EJ; Monfeuga T; Lewis LC; Ali SHL; Chandran A; Dearlove DJ; Neville MJ; Chen L; Maroteau C; Ruby MA; Hodson L
    Metabolism; 2023 Jul; 144():155563. PubMed ID: 37088121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.